共 50 条
- [1] Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemiaLeukemia, 2018, 32 : 855 - 864S Fujita论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyD Honma论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyN Adachi论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyK Araki论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyE Takamatsu论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyT Katsumoto论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyK Yamagata论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyK Akashi论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyK Aoyama论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyA Iwama论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological MalignancyI Kitabayashi论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Research Institute,Division of Hematological Malignancy
- [2] Targeting EZH1/2 to Restore Chemosensitivity in Dormant Myeloid Leukemia Stem CellsBLOOD, 2021, 138Chang, Kyung Hee论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USABasyal, Mahesh论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USAAlaniz, Zoe论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USAHonma, Daisuke论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Labs, Tokyo, Japan Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USATsutsmi, Shinji论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Labs 2, Tokyo, Japan Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USADos Santos, Cedric E.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USADaver, Naval论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USAAndreeff, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USA
- [3] Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemiaLEUKEMIA, 2018, 32 (04) : 855 - 864Fujita, S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanHonma, D.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Lab, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanAdachi, N.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Lab, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanAraki, K.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Lab, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanTakamatsu, E.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanKatsumoto, T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanYamagata, K.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanAkashi, K.论文数: 0 引用数: 0 h-index: 0机构: Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan论文数: 引用数: h-index:机构:Iwama, A.论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanKitabayashi, I.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan
- [4] Novel leukemia stem cell-targeted therapy for acute myeloid leukemia based on dual inhibition of EZH1/EZH2CANCER RESEARCH, 2016, 76Fujita, Shuhei论文数: 0 引用数: 0 h-index: 0Honma, Daisuke论文数: 0 引用数: 0 h-index: 0Araki, Kazushi论文数: 0 引用数: 0 h-index: 0Aoyama, Kazumasa论文数: 0 引用数: 0 h-index: 0Iwama, Atsushi论文数: 0 引用数: 0 h-index: 0Kitabayashi, Issay论文数: 0 引用数: 0 h-index: 0
- [5] NOVEL LEUKEMIA STEM CELL-TARGETED THERAPY FOR ACUTE MYELOID LEUKEMIA BASED ON DUAL INHIBITION OF EZH1/EZH2HAEMATOLOGICA, 2016, 101 : 222 - 222Kitabayashi, I.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanFujita, S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanTakamatsu, E.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanHonma, D.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Res Labs, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanAdachi, N.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Res Labs, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanAtsushi, I.论文数: 0 引用数: 0 h-index: 0机构: Dept Cellular & Mol Med, Hematol Malignancy 1Div, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, JapanAraki, K.论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Co Ltd, Oncol Res Labs, Tokyo, Japan Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Tokyo, Japan
- [6] Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemiaBlood Cancer Journal, 15 (1)Hiroki Akiyama论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyYuki Nishida论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyKyung Hee Chang论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyAndrea D. Bedoy论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyMuharrem Muftuoglu论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyWencai Ma论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Bioinformatics and computational biology The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyMahesh Basyal论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyZoe Hirschi论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyDaisuke Honma论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo,Department of Biostatistics The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyShinji Tsutsumi论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo,Department of Biostatistics The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyJing Wang论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Bioinformatics and computational biology The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyWeiguo Zhang论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyXuelin Huang论文数: 0 引用数: 0 h-index: 0机构: Co. Ltd.,Department of Medicine, Leukemia Service, Center for Hematologic Malignancies, Human Oncology and Pathogenesis Program The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyRaajit K. Rampal论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Comprehensive Cancer Center The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyOlalekan O. Oluwole论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Leukemia The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyDale Lee Bixby论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt University Cancer Center,undefined The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyNaval G. Daver论文数: 0 引用数: 0 h-index: 0机构: University of Michigan,undefined The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and TherapyMichael Andreeff论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy The University of Texas MD Anderson Cancer Center,Department of Leukemia, Section of Molecular Hematology and Therapy
- [7] Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cellsEMBO JOURNAL, 2013, 32 (14): : 1990 - 2000Bardot, Evan S.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USAValdes, Victor J.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USAZhang, Jisheng论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USAPerdigoto, Carolina N.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USANicolis, Silvia论文数: 0 引用数: 0 h-index: 0机构: Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USAHearn, Stephen A.论文数: 0 引用数: 0 h-index: 0机构: Cold Spring Harbor Lab, Microscopy Shared Facil, Cold Spring Harbor, NY 11724 USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USASilva, Jose M.论文数: 0 引用数: 0 h-index: 0机构: Columbia Univ, Sch Med, Irving Canc Res Ctr, Intitute Canc Genet, New York, NY USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USAEzhkova, Elena论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA
- [8] Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cellsJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S83 - S83Ezhkova, E.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USABardot, E.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USAValdes, J.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA
- [9] EZH2 inhibition induces blast differentiation in acute myeloid leukemiaCANCER RESEARCH, 2022, 82 (12)Lin, Claire论文数: 0 引用数: 0 h-index: 0机构: Brown Univ, Providence, RI USA Brown Univ, Providence, RI USAChang, Wen-I论文数: 0 引用数: 0 h-index: 0机构: Brown Univ, Providence, RI USA Brown Univ, Providence, RI USAHoneyman, Joshua N.论文数: 0 引用数: 0 h-index: 0机构: Brown Univ, Providence, RI USA Brown Univ, Providence, RI USAZhou, Lanlan论文数: 0 引用数: 0 h-index: 0机构: Brown Univ, Providence, RI USA Brown Univ, Providence, RI USAPrabhu, Varun V.论文数: 0 引用数: 0 h-index: 0机构: Chimerix Inc, Durham, NC USA Brown Univ, Providence, RI USAAllen, Joshua论文数: 0 引用数: 0 h-index: 0机构: Chimerix Inc, Durham, NC USA Brown Univ, Providence, RI USAEl-Deiry, Wafik论文数: 0 引用数: 0 h-index: 0机构: Brown Univ, Providence, RI USA Brown Univ, Providence, RI USA
- [10] EZH2 mutations in childhood acute myeloid leukemiaONKOLOGIE, 2012, 35 : 115 - 115Pflug, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyGruhn, B.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Kinder & Jugendmed, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyRinke, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanySchaefer, V论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyErnst, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Kinder & Jugendmed, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyBierbach, U.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum, Klin Kinder & Jugendmed, Leipzig, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyBeck, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Kinder & Jugendmed, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyHochhaus, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, GermanyErnst, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany